title: Sildenafil in the treatment of erectile dysfunction.
authors.forename: M J
authors.initials: MJ
authors.lastname: Saldana
authors.forename: C
authors.initials: C
authors.lastname: Villaran
authors.forename: B
authors.initials: B
authors.lastname: Alhalel
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000368:Aged; D000369:Aged, 80 and over; D007172:Erectile Dysfunction / Q000188:drug therapy*; D017809:Fatal Outcome; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010879:Piperazines / Q000009:adverse effects*; D011650:Pulmonary Alveoli; D011658:Pulmonary Fibrosis / Q000150:complications; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D015106:3',5'-Cyclic-GMP Phosphodiesterases